AI Maverick Intel has entered into a Right of First Refusal Agreement with HEAL Group Holdings Inc., providing the company with the ability to review and match third-party offers for certain HEAL assets or business units under specified conditions. The agreement, effective February 11, 2026, grants AIMV potential acquisition access across HEAL's portfolio of AI-driven healthcare technology and services operating in more than six countries. In exchange for this arrangement, AI Maverick Intel will issue 120,000,000 common shares to HEAL at a deemed price of $0.02 per share, representing total consideration of $2.4 million.
The three-year agreement provides AI Maverick Intel with a strategic position in the rapidly growing healthcare artificial intelligence market. This arrangement allows the company to potentially acquire valuable AI healthcare assets while maintaining flexibility in its investment strategy. The right of first refusal mechanism enables AIMV to evaluate competitive offers for HEAL assets before they are sold to third parties, giving the company a significant advantage in securing valuable technology and market positions. The agreement can be terminated earlier by mutual agreement between the two parties.
The significance of this announcement lies in the strategic positioning it provides AI Maverick Intel within the healthcare technology sector. By securing first refusal rights on HEAL Group's assets, the company gains potential access to established AI healthcare technologies and services across multiple international markets. This arrangement represents a calculated approach to expansion, allowing AIMV to selectively acquire assets that align with its strategic objectives while minimizing upfront capital expenditure. The healthcare AI market represents one of the fastest-growing segments in both technology and healthcare industries, with applications ranging from diagnostic tools to treatment optimization and patient management systems.
For investors and industry observers, this agreement demonstrates AI Maverick Intel's continued focus on identifying strategic opportunities at the intersection of artificial intelligence and emerging technology-enabled industries. The company's approach of securing potential acquisition rights rather than immediate purchases reflects a measured strategy for growth in competitive technology sectors. The full details of the agreement are available in the company's official announcement, which can be accessed through their corporate communications channels. Additional information about AI Maverick Intel's corporate developments and strategic initiatives is maintained through their investor relations resources.
